Clinical trials: Sputum
Octreotide, Sputum
Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients
The purpose of this study is to determine whether administration of octreotide (12-25 mcg/hour) for 72 hours in combination with the standard of care treatment is effective in reducing bronchorrhea (excessive airway secretions)…
- Trial name
- NCT02916433
- Testing
- Octreotide
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Danbury Hospital